Left atrial appendage occlusion (LAAO) has become a preferred alternative for ischemic stroke prophylaxis in patients with a high risk of cardioembolic stroke but who are contraindicated for long-term anticoagulation. While the intervention has been successful in reducing bleeding events when compared to using anticoagulation, some stroke risk still persists. We present a case of stroke related to the failure of a left atrial appendage occluder, which was found to have a peri-device leak and incomplete endothelialization. In our case, we also believe these may have been exacerbated by comorbid severe mitral regurgitation. While current post-procedural protocols do address management of specific findings predictive of device failure, our patient still suffered from ischemic stroke despite following guidelines. Based on current outcome studies on LAAO, he may have been at higher risk than appreciated. His surveillance imaging at post-operative day 45 revealed a small peri-device leak of < 5 mm, which is now found to be associated with a higher embolic stroke risk than larger leaks of > 5 mm. Moreover, his mitral regurgitation, which was severe and borderline symptomatic, remained undertreated for a prolonged period. In cases of similar comorbidities, one might consider exploring the role of concomitant endovascular mitral repair and LAAO to optimize outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332190PMC
http://dx.doi.org/10.7759/cureus.40214DOI Listing

Publication Analysis

Top Keywords

ischemic stroke
12
left atrial
12
atrial appendage
12
incomplete endothelialization
8
appendage occluder
8
stroke risk
8
peri-device leak
8
mitral regurgitation
8
stroke
7
acute ischemic
4

Similar Publications

Background: Carotid webs are rare nonatherosclerotic disorders in the carotid artery and are increasingly recognized as factors of ischemic stroke in the young population. Asymptomatic webs can be treated with antithrombotic therapy, whereas symptomatic cases frequently require surgical interventions, including carotid endarterectomy (CEA). However, guidelines for the optimal timing of these treatments remain unestablished, especially compared to atherosclerotic stenotic lesions, due to the rarity of carotid webs.

View Article and Find Full Text PDF

Background: Total intravenous anesthesia (TIVA)-based and volatile-based general anesthesia have different effects on cerebral hemodynamics. The current work compares these 2 regimens in acute ischemic stroke patients undergoing endovascular therapy.

Methods: We conducted a systematic literature search across MEDLINE, Embase, Cochrane, CINAHL, Web of Science, and Scopus.

View Article and Find Full Text PDF

High concentrations of neutrophil degranulation products in the plasma and thrombi are poor prognostic indicators in patients with acute ischemic stroke (AIS). This study aimed to identify candidate effectors capable of mediating neutrophil degranulation post-AIS, and to reveal their underlying epigenetic mechanisms. Microarrays and ChIP-seq were applied to analyze the neutrophils of patients with AIS.

View Article and Find Full Text PDF

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke.

J Vis Exp

January 2025

Department of Physiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University;

Stroke is a leading cause of death and disability worldwide. Most cases of stroke are ischemic and result from the occlusion of the middle cerebral artery (MCA). Current pharmacological approaches for the treatment of ischemic stroke are limited; therefore, novel therapies providing effective neuroprotection against ischemic injury following stroke are urgently needed.

View Article and Find Full Text PDF

Recent guidelines for acute ischemic stroke (AIS) indicate administration of intravenous thrombolysis (IVT) in patients receiving direct oral anticoagulants (DOAC) is not firmly established and may be harmful unless certain potential parameters are met. This systematic review and meta-analysis explores safety outcomes and other clinical parameters from the growing number of publications describing patients taking a DOAC who experience an AIS that is treated acutely with IVT alone. Embase, International Pharmaceutical Abstracts, and PubMed were searched up to January 9, 2024 for studies including adult patients taking a DOAC who experienced an AIS treated with IVT and did not undergo endovascular therapy (EVT), regardless of the use of an anticoagulation reversal agent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!